Jace and Bloodbraid continue to be the main story of the Modern metagame. Adrian looks at the cards’ impact two weeks out and advises where to park investment money.
Adrian Tan
It’s too late to capitalize on Jace and Bloodbraid themselves in the MTGO market. But plenty of opportunities still exist to take advantage of the tumult caused by the unbannings.
With the Modern Pro Tour in the books, what can we expect from the next metagame evolution? Adrian looks at cards well positioned for gains one week after PT RIX.
Adrian covers some decks from Modern that are performing well but flying under the radar – what are the opportunities are in these lists?
Adrian dives into week two of the post-Rivals Standard metagame. These are the strategies flying under the radar and the cards he suggests to target.
The metagame is settling on MTGO after the Standard bannings. Which cards is Adrian buying – and which is he staying far away from?
With new cards entering Modern from Rivals of Ixalan as well as a Modern Pro Tour coming up, Adrian covers which new cards might have an impact on already-existing cards. Do you like blue cards? This one is for you.
We’ve got the full RIX spoiler now, and Adrian’s got some ideas of how the metagame might evolve around a few of the new cards.
Adrian’s got some tips today on choosing a Modern deck that has potential to both earn you tickets through grinding and through the deck increasing in value overall.
Adrian breaks down a couple emerging decks that are impacting the market, one in Modern and the other in Standard.
Once-familiar but mostly forgotten decks find their way forward in today’s Modern format! Let’s talk opportunities.
Today, Adrian revisits the most recent Standard rotation – where was money made, where was money lost, and what should we be looking at moving forward?